![Nicholas Maestas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Maestas
No open positions remaining
Net worth: 903 $ as of 31/05/2026
Profile
Nicholas Maestas worked at Immune Design Corp.
from 2014 to 2019, serving as Senior Director-Corporate Development & Operations in 2019.
From 2019 to 2021, worked at Alector, Inc. as Head-Financial Planning & Analysis.
From 2025 to 2026, worked at Tempest Therapeutics, Inc. as Chief Financial Officer, Secretary & Head-Strategy.
Education includes undergraduate studies at the University of California, Berkeley and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 590 ( 0% ) | 903 $ | 31/05/2026 |
Former positions of Nicholas Maestas
| Companies | Position | End |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Director of Finance/CFO | 05/06/2026 |
| ALECTOR, INC. | Corporate Officer/Principal | 01/07/2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01/07/2019 |
Training of Nicholas Maestas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Nicholas Maestas
